
1. emerg microbes infect. 2017 may 10;6(5):e32. doi: 10.1038/emi.2017.14.

seroepidemiology enterovirus d68 infection china.

xiang z(1)(2), li l(1), ren l(1), guo l(1), xie z(3), liu c(3), li t(4), luo
m(5), paranhos-baccalà g(6), xu w(7), wang j(1)(2).

author information: 
(1)moh key laboratory systems biology pathogens christophe mérieux
laboratory, ipb, cams-fondation mérieux, institute pathogen biology (ipb),
chinese academy medical sciences (cams) & peking union medical college,
beijing 100730, china.
(2)collaborative innovation center diagnosis treatment infectious
diseases, hangzhou 310003, china.
(3)beijing children's hospital affiliated capital university medical
sciences, beijing 100045, china.
(4)peking union medical college hospital, beijing 100005, china.
(5)beijing center diseases control prevention, beijing 100013, china.
(6)fondation mérieux, lyon 69365, france.
(7)who wpro regional polio reference laboratory ministry health key
laboratory medical virology, national institute viral disease control and
prevention, chinese center disease control prevention, beijing 102206,
china.

human enterovirus 68 (ev-d68) rarely reported virus linked 
respiratory disease. recent years, reports ev-d68 infection have
markedly increased worldwide. however, epidemiological features this
emerging infection well understood. evaluate emerging ev-d68
epidemic, isolated circulating viral strain investigated the
seroprevalence neutralizing antibodies (nabs) beijing 2004 and
2011. found titers ev-d68 nabs generally low age
groups sampled populations 2004 significantly higher 2009. 2007
to 2011, nabs ev-d68 significantly increased time. these
findings indicate ev-d68 spread widely chinese population in
recent years, although limited number cases reported.

doi: 10.1038/emi.2017.14 
pmcid: pmc5520479
pmid: 28487560  [indexed medline]

